Pharma Industry News

Breast cancer ‘breakthrough’ could end unnecessary biopsies

The novel mammography imaging system could potentially “spell an end” to unnecessary biopsies, by determining benign or malignant breast lesions.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]